Topics
Gliomas | Diagnosis | Differentiating recurrence from post-treatment changes
Home > Publications > Topics > Gliomas > Diagnosis > Differentiating recurrence from post-treatment changes
Moltoni G, Romano A, Capriotti G, Campagna G, Ascolese AM, Romano
A, Dellepiane F, Minniti G, Signore A, Bozzao A.
ASL,
DSC, DCE perfusion MRI and 18F-DOPA PET/CT in differentiating
glioma recurrence from post-treatment changes.
Radiol
Med. 2024 Aug 8. doi:
10.1007/s11547-024-01862-3. PMID:
39117936. Observational study. ˍ
Wu X, Zhang M, Jiang Q, Li M, Wu Y.
Diagnostic
accuracy of magnetic resonance diffusion tensor imaging in
distinguishing pseudoprogression from glioma recurrence: a
systematic review and meta-analysis.
Expert
Rev Anticancer Ther. 2024 Oct 14;24(11):1177-1185. doi:
10.1080/14737140.2024.2415404. PMID:
39400036. Review; Meta-analysis˰
ˍ
Amide proton transfer-weighted (APTw) MRI
Karimian-Jazi K, Enbergs N, Golubtsov E, Schregel K, Ungermann J,
Fels-Palesandro H, Schwarz D, Sturm V, Kernbach JM, Batra D, Ippen
FM, Pflüger I, von Knebel Doeberitz N, Heiland S, Bunse L,
Platten M, Winkler F, Wick W, Paech D, Bendszus M, Breckwoldt MO.
Differentiating Glioma Recurrence and
Pseudoprogression by APTw CEST MRI.
Invest
Radiol. 2024 Dec 9. doi:
10.1097/RLI.0000000000001145. PMID:
39644107. Interventional study˰
ˍ